Insider · CIK 0001546842

Apelian David

Reports to the SEC for 2 companies · NEW HAVEN, CT

sec.gov

Transactions

Companies

Filings

CIK

0001546842

Forms 4 and 5

Insider transactions

21 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-07-03	Eiger BioPharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, CEO	AAward	+750K sh	—	—	750,000
2023-01-31	Eiger BioPharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, CEO	AAward	+170K sh	—	—	170,000
2022-08-16	Eiger BioPharmaceuticals, Inc.S Sale	Director, CEO	SSale	−5,000 sh	$9.81	−$49K	11,000
2022-03-11	Eiger BioPharmaceuticals, Inc.A Award	Director, CEO	AAward	+6,000 sh	—	—	16,000
2022-03-11	Eiger BioPharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, CEO	AAward	+12K sh	—	—	12,000
2021-03-12	Eiger BioPharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, CEO	AAward	+10K sh	—	—	10,000
2021-03-12	Eiger BioPharmaceuticals, Inc.A Award	Director, CEO	AAward	+5,000 sh	—	—	10,000
2020-03-12	Eiger BioPharmaceuticals, Inc.A Award	Director, CEO	AAward	+5,000 sh	—	—	5,000
2020-03-12	Eiger BioPharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, CEO	AAward	+10K sh	—	—	10,000
2019-03-21	Eiger BioPharmaceuticals, Inc.Stock Option ( Right to Buy)A Award	Director, CEO	AAward	+111K sh	—	—	110,500
2018-03-14	Eiger BioPharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, CEO	AAward	+37K sh	—	—	37,000
2017-09-28	Eiger BioPharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, CEO	AAward	+25K sh	—	—	25,000
2017-01-17	ACHILLION PHARMACEUTICALS INCEmployee Stock OptionA Award	Chief Medical Officer	AAward	+185K sh	—	—	185,000
2016-01-20	ACHILLION PHARMACEUTICALS INCEmployee Stock OptionA Award	Chief Medical Officer	AAward	+118K sh	—	—	118,000
2015-12-30	ACHILLION PHARMACEUTICALS INCS Sale	Chief Medical Officer	SSale	−10K sh	$10.50	−$105K	0
2015-12-30	ACHILLION PHARMACEUTICALS INCEmployee Stock OptionM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−10K sh	—	—	290,000
2015-12-30	ACHILLION PHARMACEUTICALS INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+10K sh	$3.02	+$30.2K	10,000
2014-12-02	ACHILLION PHARMACEUTICALS INCEmployee Stock Option(Right to Buy)A Award	Chief Medical Officer	AAward	−175K sh	—	—	175,000
2014-12-02	ACHILLION PHARMACEUTICALS INCEmployee Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+175K sh	—	—	175,000
2013-12-17	ACHILLION PHARMACEUTICALS INCEmployee Stock Option(Right to Buy)A Award	Chief Medical Officer	AAward	−300K sh	—	—	300,000
2013-05-28	ACHILLION PHARMACEUTICALS INCEmployee Stock Option(Right to Buy)A Award	Chief Medical Officer	AAward	−200K sh	—	—	200,000

Recent filings

Accepted (ET)
Jul 64
Apelian David0001140361-23-033483
SEC(opens sec.gov)
Feb 24
Apelian David0001567619-23-001760
SEC(opens sec.gov)
Aug 184
Apelian David0001567619-22-016461
SEC(opens sec.gov)
Mar 114
Apelian David0001140361-22-009254
SEC(opens sec.gov)
Mar 154
Apelian David0001209191-21-020572
SEC(opens sec.gov)
Mar 134
Apelian David0001209191-20-018973
SEC(opens sec.gov)
Mar 264
Apelian David0001209191-19-021286
SEC(opens sec.gov)
Mar 164
Apelian David0001209191-18-020451
SEC(opens sec.gov)
Oct 64
Apelian David0001209191-17-056344
SEC(opens sec.gov)
Jan 194
ACHILLION PHARMACEUTICALS INC0001209191-17-004597
SEC(opens sec.gov)
Jan 224
ACHILLION PHARMACEUTICALS INC0001209191-16-093101
SEC(opens sec.gov)
Dec 304
ACHILLION PHARMACEUTICALS INC0001209191-15-087387
SEC(opens sec.gov)
Dec 54/A
ACHILLION PHARMACEUTICALS INC0001181431-14-038085
SEC(opens sec.gov)
Dec 44
ACHILLION PHARMACEUTICALS INC0001181431-14-037954
SEC(opens sec.gov)
Dec 194
ACHILLION PHARMACEUTICALS INC0001181431-13-063798
SEC(opens sec.gov)

Companies

Address

C/O ACHILLION PHARMACEUTICALS, INC 300 GEORGE STREET

NEW HAVEN, CT, 06511